CYPHERPUNK TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 2.81 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2026-08-12
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.81M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.62M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.42M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.88M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2026-06-30 | 2.81M shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 2.62M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 2.42M shares 10-K · filed 2026-03-16 |
| 2025-09-30 | 2.88M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 3.64M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 3.29M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 2.84M shares 10-K · filed 2025-03-26 |
| 2024-09-30 | 2.40M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 2.02M shares 10-Q · filed 2024-08-12 |
| 2024-03-31 | 1.66M shares 10-Q · filed 2024-05-13 |
| 2023-12-31 | 1.38M shares 10-K · filed 2024-03-18 |
| 2023-09-30 | 1.11M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 959.28K shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 8.25M shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 7.54M shares 10-K · filed 2023-03-24 |
| 2022-09-30 | 6.91M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 6.50M shares 10-Q · filed 2022-08-12 |
| 2022-03-31 | 5.98M shares 10-Q · filed 2022-05-13 |
| 2021-12-31 | 5.42M shares 10-K · filed 2022-03-11 |
| 2021-09-30 | 4.87M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 4.31M shares 10-Q · filed 2021-08-13 |
| 2021-03-31 | 3.91M shares 10-Q · filed 2021-05-14 |
| 2020-12-31 | 3.48M shares 10-K · filed 2021-03-12 |
| 2020-09-30 | 3.11M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 2.79M shares 10-Q · filed 2020-08-13 |
| 2020-03-31 | 2.57M shares 10-Q · filed 2020-05-14 |
| 2019-12-31 | 2.40M shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 2.12M shares 10-Q · filed 2019-11-14 |
| 2019-06-30 | 1.89M shares 10-Q · filed 2019-08-09 |
| 2019-03-31 | 1.70M shares 10-Q · filed 2019-05-15 |
| 2018-12-31 | 1.60M shares 10-K · filed 2019-04-01 |
| 2018-09-30 | 1.44M shares 10-Q · filed 2018-11-09 |
| 2018-06-30 | 1.31M shares 10-Q · filed 2018-08-08 |
| 2018-03-31 | 1.17M shares 10-Q/A · filed 2018-08-08 |
| 2017-12-31 | 716.32K shares 10-K · filed 2018-02-23 |
| 2017-09-30 | 692.10K shares 10-Q · filed 2017-11-13 |
| 2017-06-30 | 677.24K shares 10-Q · filed 2017-08-11 |
| 2017-03-31 | 664.77K shares 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |